UNSPSC 51422344: Dexamethasone trimethyl acetate

This classification denotes a therapeutic glucocorticoid and antiemetic agent with the molecular formula C27H37FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K182597N9C, chemically known as pregna-1,4-diene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11.beta.,16.alpha.)-, but more generally known as dexamethasone trimethyl acetate, which bears US NIH Compound Identifier 63040.

European Medicines Agency schedules dexamethasone trimethyl acetate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07017MIG. Most nations, for tariff purposes, schedule dexamethasone trimethyl acetate under HS 29372200. SMILES: C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C(C)(C)C)O)C)O)F)C.

UNSPSC 51422344 Dexamethasone trimethyl acetate is a Commodity code that represents a pharmaceutical steroid, but the recent state and local procurement activity under this code shows a significant mismatch: Seminole County, Florida's most recent posting (IFB 60459723LAS) solicits naloxone and safe drug deactivation systems for community health initiatives, which falls outside the scope of the dexamethasone product itself. State and local governments use pharmaceutical codes in this family to procure medications and pharmaceutical supplies for health departments, county health systems, correctional facilities, emergency medical services, and community health programs, though the current opportunities block reflects a misclassification rather than genuine purchasing activity aligned with dexamethasone.

Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023 (note the inconsistent dates in the source), requests 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement requires electronic submission through the county's e-Procurement Portal, includes all shipping and delivery costs in the bid, and imposes standard compliance requirements such as drug-free workplace certification, E-Verify compliance, workers' compensation insurance, and commercial general liability coverage. The contract structure includes an initial two-year term with a one-year renewal option and a three-month probationary period. Given the mismatch between the dexamethasone pharmaceutical code and the actual naloxone procurement being tracked under it, this code shows limited directly relevant recent activity for vendors supplying dexamethasone trimethyl acetate to state and local buyers.